BCOR is recognized as a gene fusion partner in a variety of mesenchymal neoplasms, whereas BCOR–ITD are found in up to 70% of CCSK and in some high grade endometrial sarcomas. Here, BCOR is linked to mesenchymal cell neoplasm.